South African Research Chair in Applied Proteomics & Chemical Biology; Full Member & Deputy Director Institute of Infectious Disease and Molecular Medicine (IDM); Head of Division Chemical and Systems Biology, Department of Integrative Biomedical Sciences, Faculty of Health Sciences, University of Cape Town; Head, African Network for Drugs & Diagnostics Innovation (ANDI) Centre of Excellence in Proteomics & Genomics.
Jonathan Blackburn applies the expertise he has gained in both academia and in a UK start-up biotech environment to drive new independent and collaborative translational research programs aimed at providing a new level of understanding and prediction concerning the individual nature of disease progression and of drug response.
Jonathan's research strategy is to leverage his Research Group's established technological platforms, technical expertise, and clinical collaborations to create internationally competitive, interdisciplinary clinical proteomics research programs that have a strong translational emphasis. Their overarching goal is to combine basic and clinical research in order to create a pipeline for each lead program from discovery through to quantitation and ultimately to application in the human health sector.
Jonathan's academic expertise ranges from mechanistic enzymology, protein biochemistry, molecular biology and proteomics, to the creation of novel biomolecules by in vitro evolution. He is currently particularly interested in the translational applications of custom protein microarrays, mass spectrometry-based proteomics & metabolomics, and genomics in diagnostic marker discovery and validation, in unraveling molecular mechanisms of disease, and in the high throughput study of protein-drug interactions, as well as in studying the effects of polymorphic variation on protein function.
Alula, M.T., Krishnan, S., Hendricks, N.R., Karamchand, L., Blackburn, J.M. Identification and quantitation of pathogenic bacteria via in-situ formation of silver nanoparticles on cell walls, and their detection via SERS. Microchimica Acta (2017) 184(1):219-227
Soares, N.C., Bou, G., Blackburn, J.M. Editorial: Proteomics of microbial human pathogens. Frontiers in Microbiology (2016) 7 NOV, 1742
Lennard, K.S., Goosen, R.W., Blackburn, J.M. Bacterially-associated transcriptional remodelling in a distinct genomic subtype of colorectal cancer provides a plausible molecular basis for disease development. PLoS ONE (2016) 11,11
Parvez, M., Qhanya, L.B., Mthakathi, N.T., Kgosiemang, I.K.R., Bamal, H.D., Pagadala, N.S., Xie, T., Yang, H., Chen, H., Theron, C.W., Monyaki, R., Raselemane, S.C., Salewe, V., Mongale, B.L., Matowane, R.G., Abdalla, S.M.H., Booi, W.I., Van Wyk, M., Olivier, D., Boucher, C.E., Nelson, D.R., Tuszynski, J.A., Blackburn, J.M., Yu, J.-H., Mashele, S.S., Chen, W., Syed, K. Molecular evolutionary dynamics of cytochrome P450 monooxygenases across kingdoms: Special focus on mycobacterial P450s. Scientific Reports (2016) 6:33099
Soares, N.C., Blackburn, J.M. Mass spectrometry targeted assays as a tool to improve our understanding of post-translational modifications in pathogenic bacteria. Frontiers in Microbiology (2016) 7 AUG, 1216
Blackburn, J.M., Martens, L. The challenge of metaproteomic analysis in human samples. Expert Review of Proteomics (2016) 13(2):135-138
Peters, J.S., Calder, B., Gonnelli, G., Degroeve, S., Rajaonarifara, E., Mulder, N., Soares, N.C., Martens, L., Blackburn, J.M. Identification of quantitative proteomic differences between Mycobacterium tuberculosis lineages with altered virulence. Frontiers in Microbiology (2016) 7 MAY, 813
Wernher & Beit Building North level 3
UCT Faculty of Health Sciences